Continuous intravenous infusion (one-compartment model)

Slides:



Advertisements
Similar presentations
Karunya Kandimalla, Ph.D
Advertisements

CHAPTER 4 INTRAVENOUS INFUSION.
PHARMACOKINETIC MODELS
Instant Clinical Pharmacology E.J. Begg
First, zero, pseudo-zero order elimination Clearance
Clinical Pharmacokinetics
PHARMACOKINETIC.
DISPOSITION OF DRUGS The disposition of chemicals entering the body (from C.D. Klaassen, Casarett and Doull’s Toxicology, 5th ed., New York: McGraw-Hill,
HOW DO I DESIGN AND ADJUST A DOSAGE REGIMEN?. PHARMACOKINETICS WHAT IS THE BEST WAY TO GAIN AN UNDERSTANDING OF HOW TO DESIGN AND ADJUST A DOSAGE REGIMEN?
Pharmacokinetics of Drug Absorption
Pharmacokinetics Questions
Nonlinear pharmacokinetics
Two-compartment model
Pharmacokinetics & Pharmacodynamics of Controlled Release Systems Presented By: Govardhan.P Dept. of pharmaceutics, University College of Pharmaceutical.
1 Intravenous Infusion Equations Some drugs are administered using a continuous intravenous infusion, and if the infusion is discontinued the serum concentration/time.
One-compartment open model: Intravenous bolus administration
Multiple IV Dosing Pharmacokinetic Research, Bioequivalence Studies,
Week 3 - Biopharmaceutics and Pharmacokinetics
Index of Simulations 1-Compartment, IV bolus 1-Compartment, IV infusion: Steady- State1-Compartment, IV infusion: Steady- State 1-Compartment, IV infusion:
Laplace transformation
Practical Pharmacokinetics
Practical Pharmacokinetics September 11, 2007 Frank F. Vincenzi.
Week 4 - Biopharmaceutics and Pharmacokinetics
Dose Adjustment in Renal and Hepatic Disease
Toxicokinetic Calculations
Dosing Regimen Design Infusion regimen.
Gokaraju Rangaraju College of Pharmacy
Module 2 # 3 Pharmacokinetics how to make sense of the previous lesson or why do I have to learn this stuff?
INTRAVENOUS INFUSION.
VM 8314 Dr. Jeff Wilcke Pharmacokinetic Modeling (describing what happens)
CLEARANCE CONCEPTS Text: Applied Biopharm. & PK
University of Jordan-Faculty of Pharmacy
The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida.
Nonlinear Pharmacokinetics
Pharmacokinetics Introduction
Infusions Mark Tomlin Consultant Pharmacist: Critical Care Southampton University Hospitals NHS Trust.
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
PHARMACOKINETIC MODELS
1-Compartment Oral Dosing 400 mg of moxifloxacin is administered orally to Mr BB, a 68 yr old male who weighs 75 kg. Blood samples were drawn following.
Area under the plasma concentration time curve. IMPORTANCE OF AUC Pharmacokinetics - measurement of bioavaibility absolute, relative Biopharmaceutics.
Intravenous bolus administration: monitoring drug in urine
One Compartment Open Model IV bolus
Intravenous Infusion Previous rates of administration were instantaneous IV bolus and first order absorption. As a rate (mg/hr) a first order rate constantly.
The General Concepts of Pharmacokinetics and Pharmacodynamics
Multiple dosing: intravenous bolus administration
1 Single-dose kinetics Plasma [Drug] curve Upon administration [drug] plasma reaches a max Then begins to decline as the Drug is eliminated Cp max = max.
Noncompartmental Models. Introduction The noncompartmental approach for data analysis does not require any specific compartmental model for the system.
Clinical Pharmacokinetics Fundamental hypothesis: a relationship exists between the pharmacological or toxic response to a drug and the accessible concentration.
BIOPHARMACEUTICS.
Phoenix WinNonLin Assignment Due Today Access Phoenix remotely.
Prof. Dr. Henny Lucida, Apt
Design of Sustained Release Dosage Forms
Clinical Pharmacokinetic Equations and Calculations
Time Plasma Conc (hr) (mg/L) Below limit of detection 1 Compartment IV Analysis & Renal Elimination 500 mg of tobramycin.
Objectives Compartment Modeling of Drugs Models describing drug concentration-time profiles Multi-compartment Models.
Pharmacokinetic Questions
Pharmacokinetics 3rd Lecture
MULTIPLE DOSAGE REGIMEN
Compartmental Models and Volume of Distribution
Pharmacokinetics Tutoring
Lecture-8 Biopharmaceutics
Pharmacokinetic Modeling (describing what happens)
PHARMACOKINETICS Allie punke
Pharmacokinetics Tutoring
Dosing Regimen Concepts: 2-C, MM, Individualization principles
Quantitative Pharmacokinetics
Clinical Pharmacokinetics
REFERENCE: APPLIED CLINICAL Slideshow by: lecturer HADEEL DELMAN
Presentation transcript:

Continuous intravenous infusion (one-compartment model) Dr Mohammad Issa

Theory of intravenous infusion The drug is administered at a selected or calculated constant rate (K0) (i.e. dX/dt), the units of this input rate will be those of mass per unit time (e.g.mg/hr). The constant rate can be calculated from the concentration of drug solution and the flow rate of this solution, For example, the concentration of drug solution is 1% (w/v) and this solution is being infused at the constant rate of 10mL/hr (solution flow rate). So 10mL of solution will contain 0.1 g (100 mg) drug. The infusion rate (K0) equals to the solution flow rate multiplied by the concentration In this example, the infusion rate will be 10mL/hr multiplied by 100 mg/10 mL, or 100mg/hr. The elimination of drug from the body follows a first

IV infusion During infusion Post infusion

IV infusion: during infusion where K0 is the infusion rate, K is the elimination rate constant, and Vd is the volume of distribution

Steady state ≈ steady state concentration (Css)

Steady state At steady state the input rate (infusion rate) is equal to the elimination rate. This characteristic of steady state is valid for all drugs regardless to the pharmacokinetic behavior or the route of administration.

Fraction achieved of steady state concentration (Fss) since , previous equation can be represented as:

Fraction achieved of steady state concentration (Fss) or

Time needed to achieve steady state time needed to get to a certain fraction of steady state depends on the half life of the drug (not the infusion rate)

Example What is the minimum number of half lives needed to achieve at least 95% of steady state? At least 5 half lives (not 4) are needed to get to 95% of steady state

Example A drug with an elimination half life of 10 hrs. Assuming that it follows a one compartment pharmacokinetics, fill the following table:

Example Time Fss 10 30 50 70 90

Number of elapsed half-lives Example Time Number of elapsed half-lives Fss 10 1 0.5 30 3 0.875 50 5 0.969 70 7 0.992 90 9 0.998

IV infusion + Loading IV bolus During constant rate IV administration, the drug accumulates until steady state is achieved after five to seven half-lives This can constitute a problem when immediate drug effect is required and immediate achievement of therapeutic drug concentrations is necessary such as in emergency situations In this ease, administration of a loading dose will be necessary. The loading dose is an IV holus dose administered at the time of starting the IV infusion to achieve faster approach to steady state. So administration of an IV loading dose and starting the constant rate IV infusion simultaneously can rapidly produce therapeutic drug concentration. The loading dose is chosen to produce Plasma concentration similar or close to the desired plasma concentration that will be achieved by the IV infusion at steady state

IV infusion + Loading IV bolus

IV infusion + Loading IV bolus To achieve a target steady state conc (Css) the following equations can be used: For the infusion rate: For the loading dose:

IV infusion + Loading IV bolus The conc. resulting from both the bolus and the infusion can be described as: Ctotal =Cinfusion + Cbolus

IV infusion + Loading IV bolus: Example Derive the equation that describe plasma concentration of a drug with one compartment PK resulting from the administration of an IV infusion (K0= Css∙Cl ) and a loading bolus (LD= Css∙Vd) that was given at the start of the infusion

IV infusion + Loading IV bolus: Example Ctotal =Cinfusion + Cbolus Cinfusion: Cbolus:

IV infusion + Loading IV bolus: Example Ctotal =Cinfusion + Cbolus

Scenarios with different LD Concentration Half-lives Case A Infusion alone (K0= Css∙Cl) Case B Infusion (K0= Css∙Cl) loading bolus (LD= Css∙Vd) Case D loading bolus (LD< Css∙Vd) Case C loading bolus (LD > Css∙Vd)

Changing Infusion Rates Increasing the infusion rate results in a new steady state conc. 5-7 half-lives are needed to get to the new steady state conc Concentration Half-lives 5-7 half-lives are needed to get to steady state Decreasing the infusion rate results in a new steady state conc. 5-7 half-lives are needed to get to the new steady state conc

Changing Infusion Rates The rate of infusion of a drug is sometimes changed during therapy because of excessive toxicity or an inadequate therapeutic response. If the object of the change is to produce a new plateau, then the time to go from one plateau to another—whether higher or lower—depends solely on the half-life of the drug.

C* (Concentration at the end of the infusion) Post infusion phase During infusion Post infusion C* (Concentration at the end of the infusion)

Post infusion phase data Half-life and elimination rate constant calculation Volume of distribution estimation

Elimination rate constant calculation using post infusion data K can be estimated using post infusion data by: Plotting log(Conc) vs. time From the slope estimate K:

Volume of distribution calculation using post infusion data If you reached steady state conc (C* = CSS): where k is estimated as described in the previous slide

Volume of distribution calculation using post infusion data If you did not reached steady state (C* = CSS(1-e-kT)):

Time relative to infusion cessation (hr) Example 1 Following a two-hour infusion of 100 mg/hr plasma was collected and analysed for drug concentration. Calculate kel and V. Time relative to infusion cessation (hr) 1 3 7 10 16 22 Cp (mg/L) 12 9 8 5 3.9 1.7

Time is the time after stopping the infusion

Example 1 From the slope, K is estimated to be: From the intercept, C* is estimated to be:

Example 1 Since we did not get to steady state:

Example 2 Estimate the volume of distribution (22 L), elimination rate constant (0.28 hr-1), half-life (2.5 hr), and clearance (6.2 L/hr) from the data in the following table obtained on infusing a drug at the rate of 50 mg/hr for 16 hours. Time (hr) 2 4 6 10 12 15 16 18 20 24 Conc (mg/L) 3.48 5.47 6.6 7.6 7.8 8 4.6 2.62 0.85

Example 2

Example 2 Calculating clearance: It appears from the data that the infusion has reached steady state: (CP(t=15) = CP(t=16) = CSS)

Example 2 Calculating elimination rate constant and half life: From the post infusion data, K and t1/2 can be estimated. The concentration in the post infusion phase is described according to: where t1 is the time after stopping the infusion. Plotting log(Cp) vs. t1 results in the following:

Example 2

Example 2 K=-slope*2.303=0.28 hr-1 Half life = 0.693/K=0.693/0.28= 2.475 hr Calculating volume of distribution:

Example 3 A drug that displays one compartment characteristics was administered as an IV bolus of 250 mg followed immediately by a constant infusion of 10 mg/hr for the duration of a study. Estimate the values of the volume of distribution (25 L), elimination rate constant (0.1hr-1), half-life (7), and clearance (2.5 L/hr) from the data in the following table

Example 3 Time(hr) 5 20 45 50 Conc(mg/L) 10 7.6 4.8 4.0

Example 3 The equation that describes drug concentration is: a- Calculating volume of distribution: At time zero,

Example 3 b- Calculating elimination rate constant and half life: Since the last two concentrations (at time 45 and 50 hrs) are equal, it is assumed that a steady state situation has been achieved. Half life = 0.693/K=0.693/0.1= 6.93 hr

Example 3 c- Calculating clearance:

Example 4 For prolonged surgical procedures, succinylcholine is given by IV infusion for sustained muscle relaxation. A typical initial dose is 20 mg followed by continuous infusion of 4 mg/min. the infusion must be individualized because of variation in the kinetics of metabolism of suucinylcholine. Estimate the elimination half-lives of succinylcholine in patients requiring 0.4 mg/min and 4 mg/min, respectively, to maintain 20 mg in the body. (35 and 3.5 min)

Example 4 For the patient requiring 0.4 mg/min:

Example 5 A drug is administered as a short term infusion. The average pharmacokinetic parameters for this drug are: K = 0.40 hr-1 Vd = 28 L This drug follows a one-compartment body model.

Example 5 1) A 300 mg dose of this drug is given as a short-term infusion over 30 minutes. What is the infusion rate? What will be the plasma concentration at the end of the infusion? 2) How long will it take for the plasma concentration to fall to 5.0 mg/L? 3) If another infusion is started 5.5 hours after the first infusion was stopped, what will the plasma concentration be just before the second infusion?

Example 5 1) The infusion rate (K0) = Dose/duration = 300 mg/0.5 hr = 600 mg/hr. Plasma concentration at the end of the infusion: Infusion phase:

Example 5 2) Post infusion phase: The concentration will fall to 5.0 mg/L 1.66 hr after the infusion was stopped.

Example 5 3) Post infusion phase (conc 5.5 hrs after stopping the infusion):